Vascular change measured with independent component analysis of dynamic susceptibility contrast MRI predicts bevacizumab response in high-grade glioma.
about
Quantitative Perfusion and Permeability Biomarkers in Brain Cancer from Tomographic CT and MR ImagesCurrent standards and new concepts in MRI and PET response assessment of antiangiogenic therapies in high-grade glioma patientsVascular biomarkers derived from dynamic contrast-enhanced MRI predict response of vestibular schwannoma to antiangiogenic therapy in type 2 neurofibromatosisEffect of contrast leakage on the detection of abnormal brain tumor vasculature in high-grade glioma.Hypervascular tumor volume estimated by comparison to a large-scale cerebral blood volume radiographic atlas predicts survival in recurrent glioblastoma treated with bevacizumab.Delayed contrast extravasation MRI: a new paradigm in neuro-oncologyLessons from anti-vascular endothelial growth factor and anti-vascular endothelial growth factor receptor trials in patients with glioblastoma.Impact of Software Modeling on the Accuracy of Perfusion MRI in Glioma.Glioblastoma: Defining Tumor Niches.Improved Leakage Correction for Single-Echo Dynamic Susceptibility Contrast Perfusion MRI Estimates of Relative Cerebral Blood Volume in High-Grade Gliomas by Accounting for Bidirectional Contrast Agent Exchange.Multivoxel ¹H MR spectroscopy is superior to contrast-enhanced MRI for response assessment after anti-angiogenic treatment of orthotopic human glioma xenografts and provides handles for metabolic targetingPreoperative dynamic contrast-enhanced MRI correlates with molecular markers of hypoxia and vascularity in specific areas of intratumoral microenvironment and is predictive of patient outcome.Progressing Bevacizumab-Induced Diffusion Restriction Is Associated with Coagulative Necrosis Surrounded by Viable Tumor and Decreased Overall Survival in Patients with Recurrent Glioblastoma.Update on bevacizumab and other angiogenesis inhibitors for brain cancer.Arterial spin-labeling perfusion MRI stratifies progression-free survival and correlates with epidermal growth factor receptor status in glioblastoma.Evaluation of Encephaloduroarteriosynangiosis Efficacy Using Probabilistic Independent Component Analysis Applied to Dynamic Susceptibility Contrast Perfusion MRI.Early perfusion MRI predicts survival outcome in patients with recurrent glioblastoma treated with bevacizumab and carboplatin.Classification of tumor area using combined DCE and DSC MRI in patients with glioblastoma.Survival prediction based on qualitative MRI diffusion signature in patients with recurrent high grade glioma treated with bevacizumab.Imaging biomarkers guided anti-angiogenic therapy for malignant gliomas
P2860
Q26743358-E434AA9A-2694-48FF-ABB9-7E4EA8E273DBQ26853308-ADF5720B-4E1B-4235-BC26-C606ADBD7C34Q30393183-A569920D-8192-46C7-81E6-C44F6C39D803Q35047716-A72877CE-8751-4190-890C-6E267DEB54AAQ35093286-A59A7FD0-AF5C-442D-80BC-B1B79381706EQ35788925-B4CA819F-2BCC-4A39-B01C-84884B39D5A2Q35895174-7723C679-AE84-420E-99ED-19F979269403Q36378153-F9D96F1A-9093-494D-8489-974579A62DC2Q36796616-40825EC6-13C2-4207-937E-1D7FCE93C944Q37172332-19F9BA69-2E16-45B3-B998-CA750EA4C248Q37312731-963F4191-F8B7-4166-B219-70648EB4B0FEQ37492118-B8CF59A7-6754-4B67-A69B-91BEAB8B1A21Q37510450-FD035C82-1E21-4CC8-B478-3A65DCE55FE5Q38106370-B27AA443-F2CE-4C9E-9A7F-7F6B44F787E0Q41646607-F5C5E305-A476-4423-9222-06B8D2021F25Q45931574-B1D42933-BB3F-4974-A780-7CDDCEA00194Q48192001-6C73E455-6D7D-4DF6-A2C3-0BD7572382E3Q48465641-F9D45C7E-1A27-44E0-B981-9EB88181CCF4Q55035317-63D9A5D2-E594-4589-8152-05C60FD76930Q57177114-49BF0AD2-BECD-4010-9412-58ABF014FDCD
P2860
Vascular change measured with independent component analysis of dynamic susceptibility contrast MRI predicts bevacizumab response in high-grade glioma.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Vascular change measured with ...... response in high-grade glioma.
@ast
Vascular change measured with ...... response in high-grade glioma.
@en
type
label
Vascular change measured with ...... response in high-grade glioma.
@ast
Vascular change measured with ...... response in high-grade glioma.
@en
prefLabel
Vascular change measured with ...... response in high-grade glioma.
@ast
Vascular change measured with ...... response in high-grade glioma.
@en
P2093
P2860
P356
P1433
P1476
Vascular change measured with ...... response in high-grade glioma
@en
P2093
Alex D Cohen
Jennifer Connelly
Mark G Malkin
Melissa A Prah
Peter S LaViolette
Scott D Rand
Wade M Mueller
P2860
P304
P356
10.1093/NEUONC/NOS323
P577
2013-02-03T00:00:00Z